| | Variable | Number of patients | | n(), median (IQR) or mean (±SD†) | n=93 |
| | Age (years) | 60,9 (50,8 – 71,1) |
| | Male gender | 64 (68,8) |
| | Time on dialysis (months) | 48,5 (34,6 – 88,4) |
| | Dry weight (Kg) | 63 (54 – 73) |
| | Interdialytic weight gain (Kg) | 1,5 (1 – 2,3) |
| | Etiology of CKD | | | Diabetes mellitus | 36 (38,7) | | Hypertension | 31 (33,3) | | Primary glomerulopathy and autoimmune disease | 10 (10,7) | | Obstructive | 3 (3,23) | | Polycystic kidney disease | 6 (6,46) | | Other causes | 7(7,53) |
| | Dialysis related parameters | | | Pre-dialysis systolic blood pressure (mmHg) | 132 (± 21,3) | | Pre-dialysis diastolic blood pressure (mmHg) | 74,8 (± 16,6) | | Post-dialysis systolic blood pressure (mmHg) | 133 (± 20,2) | | Post-dialysis diastolic blood pressure (mmHg) | 73 (± 12,3) | | Therapy time (minutes) | 244 (± 14,1) | | Dialyzer | | | Revaclear 300 | 42 (45,2) | | Revaclear 400 | 46 (49,5) | | Polyflux 140H | 5 (5,38) | | Type of extracorporeal system anticoagulation | | | Unfractionated heparin | 86 (92,5) | | Low molecular weight heparin | 4 (4,3) | | No anticoagulation | 3 (3,23) | | Single pool Kt/V | 1.57 (1.43 – 1,8) | | nPCR | 1,04 (± 0.2) | | Malnutrition-Inflammation Score (MIS) | 5 (4 – 7) | | Protein intake (grams/day) | 68 (58 – 75) | | Lipid intake (grams/day) | 42,6 (± 12,5) | | Carbohydrate intake (grams/day) | 197 (± 44,2) |
| | Laboratory parameters | | | Serum albumin (gr/dL) | 4,21(± 0,31) | | PTHi ‡ (ng/mL) | 388 (242 – 573) | | Calcium (mg/dL) | 8,75 (±0,62) | | Phosphate (mg/dL) | 4,63 (±1,19) | | Potassium (mEq/L) | 5 (± 0,63) | | Hemoglobin (g/dL) | 12,3 (± 1,64) |
| | Phosphate binding therapy | | | Calcium carbonate | 66 (71) | | Aluminum Hydroxide | 43 (46,2) | | Sevelamer Chlorhydrate | 4 (4,3) |
|
|
